サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1592593

アジア太平洋の抗体探索市場の2030年までの予測 - 地域別分析：抗体タイプ別、性質別、サービス別、エンドユーザー別

Asia Pacific Antibody Discovery Market Forecast to 2030 - Regional Analysis - by Antibody Type, Nature, Services, and End User

出版日
ページ情報
英文 90 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
アジア太平洋の抗体探索市場の2030年までの予測 - 地域別分析：抗体タイプ別、性質別、サービス別、エンドユーザー別
出版日: 2024年09月16日
発行: The Insight Partners
ページ情報: 英文 90 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の抗体探索市場は、2022年には6,589億6,505万米ドルとなり、2030年までには1兆1,586億8,186万米ドルに達すると予測され、2022年から2030年までのCAGRは7.3%と推定されます。

新興国市場におけるバイオテクノロジー産業の発展がアジア太平洋の抗体探索市場を押し上げる

抗体は、抗原を同定する際の精度が非常に高いため、科学者や臨床医にとって貴重なツールとなっています。現代のバイオテクノロジーでは、基礎研究から革新的な医療評価まで、多くのプロセスで抗体が必要とされています。治療用抗体の開発は、様々な疾患の治療に新たな道を開き、この粒子の変革能力を実証しています。抗体はまた、病気の同定に正確で信頼性の高いアプローチを提供するため、抗体ベースの診断においても極めて重要です。政府からの支援の増加、官民パートナーシップの台頭、絶えず変化する疾患プロファイル、資金調達活動の増加は、アジア太平洋などの地域におけるバイオテクノロジー産業の業績を広く高めています。

経済協力開発機構（OECD）によると、2019年現在、中国は研究開発支出の点でトップランナーです。多額の投資はヘルスケア分野での先端技術の採用を促進します。アジアなどの地域の各国政府は、バイオテクノロジー企業が能力を拡大し、能力を強化することを奨励するために、税制優遇措置、安価な土地、直接投資を提供しています。したがって、台湾、マレーシア、インド、中国、シンガポール、日本といった国々は、バイオテクノロジー産業にとって最も有利な進出先のひとつです。さらに、これらのアジア諸国は、ゲノミクス、プロテオミクス、バイオマーカーの進歩を診断や治療用途に利用することに重点を置いています。このため、新興国市場ではバイオテクノロジー産業の拡大が続いており、抗体探索市場に今後数年間のビジネスチャンスが生まれると期待されています。

アジア太平洋の抗体探索市場の概要

アジア太平洋の抗体探索市場は、中国、日本、インド、韓国、オーストラリア、その他アジア太平洋に区分されます。2022年には中国が市場の最大シェアを占め、予測期間中はインドが市場の大幅なCAGRを記録すると予想されます。中国のバイオ医薬品業界は大きな転換期を迎えており、ジェネリック医薬品中心の状況からイノベーションの中心地へと発展しています。さらに、工業化の進展、新薬、ハイエンド医療機器、技術の応用が、中国における抗体探索市場の成長に寄与しています。

中国では、心血管疾患やその他の慢性疾患の有病率が急増しています。Journal of Biomedical and Environmental Scienceによると、2021年には3億3,000万人近くが心血管疾患に苦しんでいます。抗体製品は、心血管疾患に対する新規治療薬の開発に不可欠です。したがって、急増する心臓病の有病率が抗体探索の必要性を誘発します。研究センターの助けを借りて、抗体の配列を調査し、新規の抗体を開発し、既存の抗体を最適化することができます。Scimago Institute Rankingによると、2022年現在、中国には170近い医療研究センターがあり、日本（72）、オーストラリア（53）、インド（17）がこれに続いています。さらに、地理的拡大やその他の成長戦略のためにアジア太平洋諸国に注目する市場プレイヤーの増加、研究センター数の増加、政府資金の顕著な増加が、アジア太平洋の抗体探索市場成長の燃料となっています。

アジア太平洋の抗体探索市場の収益と2030年までの予測（億米ドル）

アジア太平洋の抗体探索市場のセグメンテーション

アジア太平洋の抗体探索市場は、抗体タイプ、性質、サービス、エンドユーザー、国に分類されます。

抗体タイプに基づき、アジア太平洋の抗体探索市場はモノクローナル抗体、ポリクローナル抗体、その他に区分されます。モノクローナル抗体セグメントは、2022年にアジア太平洋の抗体探索市場で最大のシェアを占めました。

性質別では、アジア太平洋の抗体探索市場はヒトおよびヒト化抗体、キメラ抗体、マウス抗体に区分されます。ヒトおよびヒト化セグメントは、2022年にアジア太平洋の抗体探索市場で最大のシェアを占めました。

サービス別では、アジア太平洋の抗体探索市場はファージディスプレイ、ハイブリドーマ、トランスジェニック動物、シングルセル、イーストディスプレイに分けられます。ファージディスプレイ分野は2022年にアジア太平洋の抗体探索市場で最大のシェアを占めました。

エンドユーザー別に見ると、アジア太平洋の抗体探索市場は製薬・バイオテクノロジー企業、研究所、その他に分類されます。製薬・バイオテクノロジー企業セグメントが2022年にアジア太平洋の抗体探索市場で最大のシェアを占めました。

国別に見ると、アジア太平洋の抗体探索市場は、中国、日本、インド、韓国、オーストラリア、その他アジア太平洋に分類されます。2022年のアジア太平洋の抗体探索市場シェアは中国が独占しました。

Charles River Laboratories International Inc、BioDuro LLC、Sartorius AG、Aragen Life Sciences Ltd、Twist Bioscience Corp、Biocytogen Pharmaceuticals Beijing Co Ltd.は、アジア太平洋の抗体探索市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋の抗体探索市場：主要市場力学

  • アジア太平洋の抗体探索市場：主要市場力学
  • 市場促進要因
    • 研究開発投資の増加
    • がん罹患率の上昇
  • 市場抑制要因
    • 生産コストの高さ
  • 市場機会
    • 発展途上地域におけるバイオテクノロジー産業の普及
  • 今後の動向
    • カスタム抗体の開発
  • 促進要因と抑制要因の影響

第5章 抗体探索市場：アジア太平洋市場分析

  • アジア太平洋の抗体探索市場収益、2020年～2030年

第6章 アジア太平洋の抗体探索市場の分析：抗体タイプ別

  • モノクローナル抗体
  • ポリクローナル抗体
  • その他

第7章 アジア太平洋の抗体探索市場の分析：性質別

  • ヒト・ヒト化抗体
  • キメラ
  • マウス

第8章 アジア太平洋の抗体探索市場の分析：サービス別

  • ファージディスプレイ
  • ハイブリドーマ
  • トランスジェニック動物
  • 酵母ディスプレイ
  • シングルセル

第9章 アジア太平洋の抗体探索市場の分析：エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 研究機関
  • その他

第10章 アジア太平洋の抗体探索市場：国別分析

    • アジア太平洋
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋

第11章 抗体探索市場：業界情勢

  • 抗体探索市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • Charles River Laboratories International Inc
  • BioDuro LLC
  • Sartorius AG
  • Aragen Life Sciences Ltd
  • Twist Bioscience Corp
  • Biocytogen Pharmaceuticals Beijing Co Ltd

第13章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Antibody Discovery Market Segmentation
  • Table 2. New Cancer Cases Worldwide, in 2020
  • Table 3. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 4. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 5. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 6. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 7. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 8. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 9. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 10. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 11. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 12. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 13. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 14. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 15. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 16. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 17. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 18. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 19. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 20. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 21. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 22. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 23. Rest of Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 24. Rest of Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 25. Rest of Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 26. Rest of Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 27. Recent Inorganic Growth Strategies in the Antibody Discovery Market
  • Table 28. Recent Organic Growth Strategies in the Antibody Discovery Market
  • Table 29. Glossary of Terms, Antibody Discovery Market

List Of Figures

  • Figure 1. Asia Pacific Antibody Discovery Market Segmentation, by Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Asia Pacific Antibody Discovery Market Revenue (US$ Million), 2020 - 2030
  • Figure 4. Asia Pacific Antibody Discovery Market Share (%) - by Antibody Type (2022 and 2030)
  • Figure 5. Monoclonal Antibodies: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 6. Polyclonal Antibodies: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Others: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Asia Pacific Antibody Discovery Market Share (%) - by Nature (2022 and 2030)
  • Figure 9. Human and Humanized: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Chimeric: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Murine: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Asia Pacific Antibody Discovery Market Share (%) - by Services (2022 and 2030)
  • Figure 13. Phage Display: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Hybridoma: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Transgenic Animal: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Yeast Display: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Single Cell: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Asia Pacific Antibody Discovery Market Share (%) - by End User (2022 and 2030)
  • Figure 19. Pharmaceutical and Biotechnology Companies: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Research Laboratories: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Others: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Asia Pacific: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 23. Asia Pacific: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 24. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 25. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 26. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 27. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 28. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 29. Rest of Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 30. Growth Strategies in the Antibody Discovery Market
目次
Product Code: BMIRE00030716

The Asia Pacific antibody discovery market was valued at US$ 6,58,965.05 million in 2022 and is expected to reach US$ 11,58,681.86 million by 2030; it is estimated to register a CAGR of 7.3% from 2022 to 2030.

Proliferation of Biotechnology Industry in Developing Regions Boosts Asia Pacific Antibody Discovery Market

The remarkable precision of antibodies in identifying antigens makes them invaluable tools for scientists and clinicians. In modern biotechnology, antibodies are required in numerous processes, from basic research to innovative medical evaluations. The development of therapeutic antibodies has opened new avenues in treating various diseases, demonstrating the transformative ability of these particles. Antibodies are also crucial in antibody-based diagnostics as they provide accurate and reliable approaches to disease identification. Growing support from governments, rising public-private partnerships, continuously changing disease profiles, and increasing funding activities are widely enhancing the performance of biotechnology industries in the regions such as Asia Pacific.

As per the Organization for Economic Co-operation and Development (OECD), China was a frontrunner in terms of R&D expenditure as of 2019. Heavy investments encourage the adoption of advanced technologies in the healthcare sector. Governments of countries in regions such as Asia offer tax incentives, cheaper land, and direct investments for encouraging biotechnology companies to expand their capacities and strengthen their capabilities. Thus, countries such as Taiwan, Malaysia, India, China, Singapore, and Japan are among the most advantageous destinations for the biotechnology industries. Furthermore, these Asian countries are more focused on using genomics, proteomics, and biomarker advancements for diagnostic and therapeutic applications. Therefore, the ongoing proliferation of biotechnology industries in developing regions is expected to create opportunities for the antibody discovery market in the coming years.

Asia Pacific Antibody Discovery Market Overview

The Asia Pacific antibody discovery market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China accounted for the largest share of the market in 2022, and India is expected to record a significant CAGR in the market during the forecast period. The biopharmaceutical industry in China is undergoing a tremendous shift, evolving from a generics-focused landscape to a thriving innovation hub. Additionally, progress in industrialization, and the application of novel drugs, high-end medical devices, and techniques contribute to the antibody discovery market growth in China.

China is experiencing an upsurge in the prevalence of cardiovascular disease and other chronic diseases. According to the Journal of Biomedical and Environmental Science, nearly 330 million people from the country suffered from cardiovascular diseases in 2021. Antibody products are crucial for the development of novel therapeutics against cardiovascular diseases. Therefore, a burgeoning prevalence of heart disease triggers the need for antibody discovery. With the help of research centers, antibody sequences can be researched, new and novel antibodies can be developed, and existing antibodies can be optimized. According to the Scimago Institute Ranking, China had nearly 170 medical research centers as of 2022, followed by Japan (72), Australia (53), and India (17). Further, the growing number of market players focusing on countries in Asia Pacific for their geographic expansion and other growth strategies, the rising count of research centers, and a notable increase in government funding fuel the antibody discovery market growth in Asia Pacific.

Asia Pacific Antibody Discovery Market Revenue and Forecast to 2030 (US$ Billion)

Asia Pacific Antibody Discovery Market Segmentation

The Asia Pacific antibody discovery market is categorized into antibody type, nature, services, end user, and country.

Based on antibody type, the Asia Pacific antibody discovery market is segmented into monoclonal antibodies, polyclonal antibodies, and others. The monoclonal antibodies segment held the largest Asia Pacific antibody discovery market share in 2022.

In terms of nature, the Asia Pacific antibody discovery market is segmented into human and humanized, chimeric, and murine. The human and humanized segment held the largest Asia Pacific antibody discovery market share in 2022.

By services, the Asia Pacific antibody discovery market is divided into phage display, hybridoma, transgenic animal, single cell, and yeast display. The phage display segment held the largest Asia Pacific antibody discovery market share in 2022.

Based on end user, the Asia Pacific antibody discovery market is categorized into pharmaceutical and biotechnology companies, research laboratories, and others. The pharmaceutical and biotechnology companies segment held the largest Asia Pacific antibody discovery market share in 2022.

Based on country, the Asia Pacific antibody discovery market is categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific antibody discovery market share in 2022.

Charles River Laboratories International Inc, BioDuro LLC, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp, and Biocytogen Pharmaceuticals Beijing Co Ltd. are some of the leading companies operating in the Asia Pacific antibody discovery market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Antibody Discovery Market - Key Market Dynamics

  • 4.1 Asia Pacific Antibody Discovery Market - Key Market Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Increasing Investments in Research & Development
    • 4.2.2 Rising Incidence of Cancer
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Production
  • 4.4 Market Opportunities
    • 4.4.1 Proliferation of Biotechnology Industry in Developing Regions
  • 4.5 Future Trends
    • 4.5.1 Developments for Custom Antibodies
  • 4.6 Impact of Drivers and Restraints:

5. Antibody Discovery Market - Asia Pacific Market Analysis

  • 5.1 Asia Pacific Antibody Discovery Market Revenue (US$ Million), 2020-2030

6. Asia Pacific Antibody Discovery Market Analysis - by Antibody Type

  • 6.1 Overview
  • 6.2 Monoclonal Antibodies
    • 6.2.1 Overview
    • 6.2.2 Monoclonal Antibodies: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Polyclonal Antibodies
    • 6.3.1 Overview
    • 6.3.2 Polyclonal Antibodies: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Others
    • 6.4.1 Overview
    • 6.4.2 Others: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Antibody Discovery Market Analysis - by Nature

  • 7.1 Overview
  • 7.2 Human and Humanized
    • 7.2.1 Overview
    • 7.2.2 Human and Humanized: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Chimeric
    • 7.3.1 Overview
    • 7.3.2 Chimeric: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Murine
    • 7.4.1 Overview
    • 7.4.2 Murine: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Antibody Discovery Market Analysis - by Services

  • 8.1 Overview
  • 8.2 Phage Display
    • 8.2.1 Overview
    • 8.2.2 Phage Display: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Hybridoma
    • 8.3.1 Overview
    • 8.3.2 Hybridoma: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Transgenic Animal
    • 8.4.1 Overview
    • 8.4.2 Transgenic Animal: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Yeast Display
    • 8.5.1 Overview
    • 8.5.2 Yeast Display: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Single Cell
    • 8.6.1 Overview
    • 8.6.2 Single Cell: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Antibody Discovery Market Analysis - by End User

  • 9.1 Overview
  • 9.2 Pharmaceutical and Biotechnology Companies
    • 9.2.1 Overview
    • 9.2.2 Pharmaceutical and Biotechnology Companies: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Research Laboratories
    • 9.3.1 Overview
    • 9.3.2 Research Laboratories: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Others
    • 9.4.1 Overview
    • 9.4.2 Others: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Antibody Discovery Market - Country Analysis

  • 10.1 Asia Pacific Antibody Discovery Market, Revenue and Forecast to 2030
    • 10.1.1 Asia Pacific: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 China
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 China: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.3 China: Antibody Discovery Market Breakdown, by Antibody Type
        • 10.1.1.1.4 China: Antibody Discovery Market Breakdown, by Nature
        • 10.1.1.1.5 China: Antibody Discovery Market Breakdown, by Services
        • 10.1.1.1.6 China: Antibody Discovery Market Breakdown, by End User
      • 10.1.1.2 Japan
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Japan: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.3 Japan: Antibody Discovery Market Breakdown, by Antibody Type
        • 10.1.1.2.4 Japan: Antibody Discovery Market Breakdown, by Nature
        • 10.1.1.2.5 Japan: Antibody Discovery Market Breakdown, by Services
        • 10.1.1.2.6 Japan: Antibody Discovery Market Breakdown, by End User
      • 10.1.1.3 India
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 India: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.3 India: Antibody Discovery Market Breakdown, by Antibody Type
        • 10.1.1.3.4 India: Antibody Discovery Market Breakdown, by Nature
        • 10.1.1.3.5 India: Antibody Discovery Market Breakdown, by Services
        • 10.1.1.3.6 India: Antibody Discovery Market Breakdown, by End User
      • 10.1.1.4 Australia
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Australia: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.3 Australia: Antibody Discovery Market Breakdown, by Antibody Type
        • 10.1.1.4.4 Australia: Antibody Discovery Market Breakdown, by Nature
        • 10.1.1.4.5 Australia: Antibody Discovery Market Breakdown, by Services
        • 10.1.1.4.6 Australia: Antibody Discovery Market Breakdown, by End User
      • 10.1.1.5 South Korea
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 South Korea: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.3 South Korea: Antibody Discovery Market Breakdown, by Antibody Type
        • 10.1.1.5.4 South Korea: Antibody Discovery Market Breakdown, by Nature
        • 10.1.1.5.5 South Korea: Antibody Discovery Market Breakdown, by Services
        • 10.1.1.5.6 South Korea: Antibody Discovery Market Breakdown, by End User
      • 10.1.1.6 Rest of Asia Pacific
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.3 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Antibody Type
        • 10.1.1.6.4 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Nature
        • 10.1.1.6.5 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Services
        • 10.1.1.6.6 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by End User

11. Antibody Discovery Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Antibody Discovery Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Charles River Laboratories International Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 BioDuro LLC
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Sartorius AG
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Aragen Life Sciences Ltd
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Twist Bioscience Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Biocytogen Pharmaceuticals Beijing Co Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms